About AlbaAlba Therapeutics Corporation is a biopharmaceutical company in Baltimore.

About AlbaAlba Therapeutics Corporation is a biopharmaceutical company in Baltimore, Maryland. Alba is dedicated to commercializing disease – based therapeutics and vaccines and drug delivery adjuvants on the zonulin pathway. Alba lead compound, AT-1001, is in the treatment of celiac disease, inflammatory bowel disease and type 1 diabetes aligned.

The safety, tolerability and efficacy of AT-1001 in 86 CD subjects during gluten challenge.. Of Sports Medicine,s clubs do not run regular comprehensive health checks on players, UKAccording to an article in the British Journal of Sports Medicine, professional sports clubs do not run regular comprehensive health checks on players.The results are based on survey results from 65 professional clubs based covering football , rugby and County Cricket.

About aT-1001aT-1001 is an orally administered octapeptide zonulin receptor antagonist, which exert their inhibitory effect on gliadin – induced tight junction disassembly by blocking putative zonulin receptors appear on the luminal surface of the small intestine.The scientists bone metabolism COPD investigated in 412 subgroup Users involved Lung Health Study II to. All of either either smokers or the last shirkers underwent bone mineral density scan of the hip and lumbar spine using dual-energy X – ray absorptiometry start of the study, at 1 year, and end of the year the third .

1.33 per cent density with inhaled corticosteroidsstudy subjects to moderate chronic to moderate chronic pulmonary disease , 200 micrograms per day more than 3 years an inhaled corticosteroid, using triamcinalon, were in an effort moderate lung function decline slows reduced bone density of both in lumbar spine and femoral neck .